LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 8 of 15: Cell count and normalized growth rate inhibition values within biological replicate 1. - Dataset (ID:20245)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Radicicol | 3.33 | uM | LJP6 | 3 | K08 | 72 | hr | 1476 | 1485 | 3734 | 0.3977 | 0.0042 |
| SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 1 | K08 | 72 | hr | 1476 | 1668 | 3788 | 0.4403 | 0.0937 |
| SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 2 | K08 | 72 | hr | 1476 | 1497 | 3731 | 0.4012 | 0.0103 |
| SK-BR-3 | Radicicol | 3.33 | uM | LJP5 | 3 | K08 | 72 | hr | 1476 | 1560 | 3796 | 0.4109 | 0.0411 |
| SK-BR-3 | Radicicol | 10 | uM | LJP6 | 1 | K07 | 72 | hr | 1476 | 1350 | 3413 | 0.3955 | -0.0715 |
| SK-BR-3 | Radicicol | 10 | uM | LJP6 | 2 | K07 | 72 | hr | 1476 | 904 | 3783 | 0.2389 | -0.3034 |
| SK-BR-3 | Radicicol | 10 | uM | LJP6 | 3 | K07 | 72 | hr | 1476 | 1118 | 3734 | 0.2994 | -0.1877 |
| SK-BR-3 | Radicicol | 10 | uM | LJP5 | 1 | K07 | 72 | hr | 1476 | 1199 | 3788 | 0.3165 | -0.1421 |
| SK-BR-3 | Radicicol | 10 | uM | LJP5 | 2 | K07 | 72 | hr | 1476 | 1176 | 3731 | 0.3152 | -0.1566 |
| SK-BR-3 | Radicicol | 10 | uM | LJP5 | 3 | K07 | 72 | hr | 1476 | 1266 | 3796 | 0.3335 | -0.1069 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 1 | G18 | 72 | hr | 1476 | 3453 | 3413 | 1.0116 | 1.0192 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 2 | G18 | 72 | hr | 1476 | 3655 | 3783 | 0.9660 | 0.9497 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP6 | 3 | G18 | 72 | hr | 1476 | 4214 | 3734 | 1.1285 | 1.1891 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 1 | G18 | 72 | hr | 1476 | 3658 | 3788 | 0.9655 | 0.9490 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 2 | G18 | 72 | hr | 1476 | 3954 | 3731 | 1.0597 | 1.0886 |
| SK-BR-3 | Withaferin A | 0.04 | uM | LJP5 | 3 | G18 | 72 | hr | 1476 | 3893 | 3796 | 1.0254 | 1.0371 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 1 | G17 | 72 | hr | 1476 | 2929 | 3413 | 0.8581 | 0.7622 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 2 | G17 | 72 | hr | 1476 | 3111 | 3783 | 0.8223 | 0.7315 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP6 | 3 | G17 | 72 | hr | 1476 | 3500 | 3734 | 0.9373 | 0.9056 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 1 | G17 | 72 | hr | 1476 | 3406 | 3788 | 0.8990 | 0.8493 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 2 | G17 | 72 | hr | 1476 | 3118 | 3731 | 0.8357 | 0.7487 |
| SK-BR-3 | Withaferin A | 0.12 | uM | LJP5 | 3 | G17 | 72 | hr | 1476 | 3821 | 3796 | 1.0064 | 1.0094 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 1 | G16 | 72 | hr | 1476 | 1262 | 3413 | 0.3697 | -0.1219 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 2 | G16 | 72 | hr | 1476 | 1603 | 3783 | 0.4237 | 0.0623 |
| SK-BR-3 | Withaferin A | 0.37 | uM | LJP6 | 3 | G16 | 72 | hr | 1476 | 1388 | 3734 | 0.3717 | -0.0452 |